FREELINE THERAPEUTICS HOLDIN (FRLN)

US35655L2060 - ADR

6.48  0 (0%)

After market: 6.48 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to FRLN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.42. This target is 29.86% above the current price.
FRLN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FRLN.
In the previous month the buy percentage consensus was at a similar level.
FRLN was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 6.486.578.428.4210.50 - 1.31% 29.86% 29.86% 62.04%
Up and Down Grades
Date Firm Action Rating
2023-11-28 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-10-18 Wedbush Downgrade Outperform -> Neutral
2023-08-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-16 Stifel Maintains Hold -> Hold
2023-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-01 Stifel Reiterate Hold -> Hold
2023-05-31 HC Wainwright & Co. Reiterate Buy
2023-04-05 Stifel Downgrade Buy -> Hold
2023-04-05 HC Wainwright & Co. Maintains Buy
2022-08-22 HC Wainwright & Co. Maintains Buy
2022-08-11 BTIG Maintains Buy
2022-02-01 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-01-07 Redburn Partners Upgrade Neutral -> Buy
2021-11-29 BTIG Initiate Buy
2021-08-18 HC Wainwright & Co. Maintains Buy
2021-08-17 JP Morgan Downgrade Overweight -> Neutral
2021-05-19 HC Wainwright & Co. Initiate Buy
2021-05-06 Guggenheim Initiate Buy
2021-04-06 Morgan Stanley Maintains Overweight
2021-03-23 Mizuho Initiate Buy
2021-03-02 Stifel Initiate Buy